Indegene provides software platforms and technology-enabled services to life sciences companies globally, including large pharma, emerging biotech, and medical device manufactures. The company helps medical affairs, sales and marketing, and regulatory teams do their jobs with higher levels of efficiency through digital transformation of otherwise manual processes.
Brighton Park Capital partnered with Indegene to bring in a team of exceptional independent board members and assist them in identifying and executing on acquisition opportunities.
19 of the top 20
global biopharma companies as customers
integrating healthcare expertise & technology
recognition by HFS Research & Everest Group
Any statement provided by a portfolio company executive has been provided with the intention of describing their personal experience having Brighton Park as an investor in their company. It is important to note that the experiences of other portfolio companies and their executives might vary from those depicted here. There is no assurance that Brighton Park's involvement with other portfolio companies will yield results comparable to those of this portfolio company. Brighton Park did not offer any form of direct compensation for the provision of these statements. Each portfolio company executive receives ordinary course compensation from their portfolio company, which may be controlled by Brighton Park, and may have other relationships with Brighton Park (including investments in Brighton Park or its affiliated funds). There may be certain inherent conflicts of interest relating to any portfolio company executive because they are employed by a Brighton Park portfolio company and receive benefits and compensation in connection with such employment. Unless otherwise noted, the information presented herein has been provided by the relevant portfolio company for illustrative purposes and may not be complete or current as of the date of viewing.